edly decreased hyperandrogenism and normalized the hypercortisolism. The main effect of ketoconazole was at the 17,20-lyase level and probably at a locus prior in steroidogenesis, i.e. at the P450SCC and/or 17\g=a\-hydroxylase level. In contrast with other studies no effect at all was seen on the 11-hydroxylase activity of P450C11. After removal of a massive adrenal carcinoma, extending into the vena cava, vena cava resection and hemihepatectomy because of liver invasion, plasma cortisol and androgen values normalized. Despite adjuvant chemotherapy with o,p'-dichlor-diphenyl-dichloretan (4000 mg daily) hyperandrogenism soon recurred and lung metastases became manifest. Within 2 months after starting combined chemotherapy with 5-fluorouracil, cisplatin, and doxorubicin lung metastases almost completely disappeared with clinical and biochemical resolution of the hyperandrogenic state.
The prognosis of adrenocortical carcinoma is very poor (1) . Temporary objective improvement in pa¬ tients with inoperable or recurrent adrenocortical carcinoma has been achieved by o,p'-dichlor-diphenyl-dichloretan (DDD) therapy (2, 3) . Very recently the use of ketoconazole has been suggested in the preoperative management of adrenocortical carcinoma. Ketoconazole is a broad spectrum antimycotic agent which is a potent inhibitor of en¬ zymes of the cytochrome P450 system in gonadal but also in adrenal steroid synthesis (4, 5) . It has been used preoperatively in Cushing's syndrome with virilization due to adrenocortical carcinoma to reduce the increased operation risk of a higher bleeding tendency, poor wound healing and thromboembolism associated with hypercortisolism, and to achieve a better metabolic control (6) (7) (8) oxycortisol and 11-deoxycortisol over cortisol, there was no significant effect of ketoconazole treatment (Fig. 1) . 17, 20 -bond scission after 17a-hydroxylation rather than 21-hydroxylation (14) . Al¬ ternatively, relative deficiency of P4äoC2i, as evi¬ denced by the increased 17 OHP/11-deoxycortisol ratio, and even more relative deficiency of P45oCn, as evidenced by the high 11-deoxycortisol/cortisol ratio, may account for the hypercortisolism being only mild in this patient (7, 8) .
The antimycotic drug ketoconazole reportedly blocks the mitochondrial P450 enzymes P450SCC
(cholesterol side-chain cleavage enzyme), P450Cn (11-hydroxylase, 18-hydroxylase and 18-methyloxidase), and P450C17 (17a-hydroxylase and 17,20-lyase) in the adrenal, testis and ovary. The efficacy of ketoconazole to inhibit cortisol production led to its trial as an inhibitor of steroidogenesis in cases of cortisol overproduction (15) (16) (17) . Very recently its efficacy was also demonstrated in patients with virilizing and feminizing adrenal carcinoma with or without hypercortisolism (6, 7, 18, 19 
